Metropolis Healthcare is currently trading at Rs. 1238.85, up by 11.20 points or 0.91% from its previous closing of Rs. 1227.65 on the BSE.
The scrip opened at Rs. 1238.90 and has touched a high and low of Rs. 1242.00 and Rs. 1223.40 respectively. So far 1077 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 1359.90 on 11-Sep-2019 and a 52 week low of Rs. 904.85 on 14-May-2019.
Last one week high and low of the scrip stood at Rs. 1321.80 and Rs. 1215.00 respectively. The current market cap of the company is Rs. 6138.86 crore.
The promoters holding in the company stood at 57.41%, while Institutions and Non-Institutions held 21.71% and 20.88% respectively.
Metropolis Healthcare’s wholly owned subsidiary — Desai Metropolis Health Services has acquired four laboratories from Doctor’s Clinical Laboratory (partnership firm), Iyer Pathology Laboratory (sole proprietary), Nagar Pathology Laboratory (sole proprietary) and Yash Clinical Laboratory (sole proprietary), for providing diagnostic and pathological testing services in Surat, Gujarat.
Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.